CRDF
CRDF
NASDAQ · Biotechnology

Cardiff Oncology Inc

$1.71
+0.09 (+5.56%)
As of Apr 1, 3:05 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +532.2% upside
Low Target $7.63
Average Target $10.81
High Target $13.89
Current Price $1.71
Current
$1.71
Target
$10.81
$7.63 $10.81 avg $13.89
Scenario Analysis
Bear Case
$7.63
346.2%
Low target
Base Case
$10.81
+532.2%
Avg target
Bull Case
$13.89
+712.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$4.56
-62.5% from high
52-Week Low
$1.48
+15.5% from low
Target vs 52W High
$10.81
+137.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%